479 related articles for article (PubMed ID: 19460075)
1. Influence of left ventricular lead position on clinical outcomes in the COMPANION study: does placement really matter?
Freedberg NA
J Cardiovasc Electrophysiol; 2009 Jul; 20(7):769-72. PubMed ID: 19460075
[No Abstract] [Full Text] [Related]
2. Influence of left ventricular lead location on outcomes in the COMPANION study.
Saxon LA; Olshansky B; Volosin K; Steinberg JS; Lee BK; Tomassoni G; Guarnieri T; Rao A; Yong P; Galle E; Leigh J; Ecklund F; Bristow MR
J Cardiovasc Electrophysiol; 2009 Jul; 20(7):764-8. PubMed ID: 19298563
[TBL] [Abstract][Full Text] [Related]
3. The Managed Ventricular pacing versus VVI 40 Pacing (MVP) Trial: clinical background, rationale, design, and implementation.
Sweeney MO; Ellenbogen KA; Miller EH; Sherfesee L; Sheldon T; Whellan D
J Cardiovasc Electrophysiol; 2006 Dec; 17(12):1295-8. PubMed ID: 17081208
[TBL] [Abstract][Full Text] [Related]
4. Managing with pacemakers and implantable cardioverter defibrillators.
Lampert R
Circulation; 2013 Oct; 128(14):1576-85. PubMed ID: 24081953
[No Abstract] [Full Text] [Related]
5. Cardiac resynchronization therapy in heart failure patients: an update.
Jeevanantham V; Daubert JP; Zareba W
Cardiol J; 2009; 16(3):197-209. PubMed ID: 19437393
[TBL] [Abstract][Full Text] [Related]
6. [Cardiac resynchronization therapy with or without defibrillation backup: everything has been written?].
Botto GL; Luzi M; Russo G; Mariconti B
G Ital Cardiol (Rome); 2010 Apr; 11(4):306-9. PubMed ID: 20677576
[No Abstract] [Full Text] [Related]
7. Upgrading to biventricular pacing/defibrillation systems in right ventricular paced congestive heart failure patients: prospective assessment of procedural parameters and response rate.
Duray GZ; Israel CW; Pajitnev D; Hohnloser SH
Europace; 2008 Jan; 10(1):48-52. PubMed ID: 18077483
[TBL] [Abstract][Full Text] [Related]
8. Lead extraction is preferred for lead revisions and system upgrades: when less is more.
Maytin M; Epstein LM; Henrikson CA
Circ Arrhythm Electrophysiol; 2010 Aug; 3(4):413-24; discussion 424. PubMed ID: 20716723
[No Abstract] [Full Text] [Related]
9. Fatal complications of pacemaker and implantable cardioverter-defibrillator implantation: medical malpractice?
Schulz N; Püschel K; Turk EE
Interact Cardiovasc Thorac Surg; 2009 Apr; 8(4):444-8. PubMed ID: 19168462
[TBL] [Abstract][Full Text] [Related]
10. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device.
Francisco GM; Sharma S; Dougherty AH; Kantharia BK
Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529
[TBL] [Abstract][Full Text] [Related]
11. Think before you pull--not every lead has to come out.
Henrikson CA; Maytin M; Epstein LM
Circ Arrhythm Electrophysiol; 2010 Aug; 3(4):409-12; discussion 412. PubMed ID: 20716722
[No Abstract] [Full Text] [Related]
12. Cardiac resynchronization therapy for heart failure.
Abraham WT; Hayes DL
Circulation; 2003 Nov; 108(21):2596-603. PubMed ID: 14638522
[No Abstract] [Full Text] [Related]
13. Interventional electrophysiology and cardiac resynchronization therapy: delivering electrical therapies for heart failure.
Burkhardt JD; Wilkoff BL
Circulation; 2007 Apr; 115(16):2208-20. PubMed ID: 17452619
[TBL] [Abstract][Full Text] [Related]
14. A futuristic perspective on clinical studies of cardiac resynchronization therapy for heart failure patients.
Tang AS; Ellenbogen KA
Curr Opin Cardiol; 2006 Mar; 21(2):78-82. PubMed ID: 16470139
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous pacemaker or implantable cardioverter-defibrillator lead removal in an attempt to improve symptomatic tricuspid regurgitation.
Nazmul MN; Cha YM; Lin G; Asirvatham SJ; Powell BD
Europace; 2013 Mar; 15(3):409-13. PubMed ID: 23193162
[TBL] [Abstract][Full Text] [Related]
16. Heart failure devices: implantable cardioverter-defibrillators and biventricular pacing therapy.
Kadish A; Mehra M
Circulation; 2005 Jun; 111(24):3327-35. PubMed ID: 15967863
[No Abstract] [Full Text] [Related]
17. Tricuspid regurgitation in patients with pacemakers and implantable cardiac defibrillators: a comprehensive review.
Al-Bawardy R; Krishnaswamy A; Bhargava M; Dunn J; Wazni O; Tuzcu EM; Stewart W; Kapadia SR
Clin Cardiol; 2013 May; 36(5):249-54. PubMed ID: 23529935
[TBL] [Abstract][Full Text] [Related]
18. Effect of pacing for soft indications on mortality and heart failure in the dual chamber and VVI implantable defibrillator (DAVID) trial.
Kutalek SP; Sharma AD; McWilliams MJ; Wilkoff BL; Leonen A; Hallstrom AP; Kudenchuk PJ;
Pacing Clin Electrophysiol; 2008 Jul; 31(7):828-37. PubMed ID: 18684279
[TBL] [Abstract][Full Text] [Related]
19. Abnormal conduction increases risk of adverse outcomes from right ventricular pacing.
Hayes JJ; Sharma AD; Love JC; Herre JM; Leonen AO; Kudenchuk PJ;
J Am Coll Cardiol; 2006 Oct; 48(8):1628-33. PubMed ID: 17045899
[TBL] [Abstract][Full Text] [Related]
20. Cardiac resynchronization therapy for mild congestive heart failure.
Technol Eval Cent Assess Program Exec Summ; 2010 Apr; 24(8):1-5. PubMed ID: 20575185
[No Abstract] [Full Text] [Related]
[Next] [New Search]
